MBII: Regalia approved for marijuana treatment in Canada

Zacks Small Cap Research - finance.yahoo.com Posted 5 years ago

By Ian Gilson, PhD, CFA

NASDAQ:MBII

READ THE FULL MBII RESEARCH REPORT

Marrone Bio Innovations (MBII) has announced that Regalia Maxx has received label approval from Canada's Pest Management Regulatory Agency for use on marijuana (Canadian:marihuana) crops in Canada.

A new distributor, Plant Products Inc., has Regalia Maxx listed on its web site as Item # 21137 available in 5L containers. Plant Products Inc . has distribution rights for Eastern and Central Canada and a distributor for Western Canada is expected to be announced in the near future.

Plant Products Inc., with HQ in Leamington, Ontario, is 75 year old full service supplier of products to the greenhouse and horticulture industry in Canada and the USA.

According to the Vineland Research and Innovation Centre biocontrol use in Canada has increased from 69% in 2014 to 92% of the growers in the survey. The number of growers using biocontrol in their integrated pest management has increased from 30% to 70 from 2014 to 2018. Growers have reduced their spending of conventional pesticides over this period.

Regalia is a fungicide that is very effective against powdery mildew, a major pest in marijuana plants. Another major pest in greenhouse cultivation is spider mites and MBI's Venerate product combats this pest. Venerate is registered in Mexico but not Canada.

SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR. 

DISCLOSURE: Zacks SCR has received compensation from the issuer directly or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks provides and Zacks receives quarterly payments totaling a maximum fee of $30,000 annually for these services. Full Disclaimer HERE.